An acquired defect associated with abnormal signaling of the platelet collagen receptor glycoprotein VI

Jianlin Qiao1, Jane F Arthur, Margaret Collecutt

  • 1Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.

Acta Haematologica
|August 28, 2012
PubMed
Abstract

Insights

Platelet glycoprotein VI (GPVI) signaling can generate reactive oxygen species (ROS) independently of Syk activation. This study reveals novel divergent pathways in GPVI signaling, impacting ROS production and platelet function in a patient with myelodysplastic syndrome.

Area of Science:

  • Hematology
  • Platelet Biology
  • Molecular Signaling

Background:

  • Platelet activation via glycoprotein VI (GPVI) involves Syk-dependent signaling and reactive oxygen species (ROS) generation.
  • Metalloproteinase-mediated shedding of GPVI can occur through various signaling pathways.

Purpose of the Study:

  • To analyze platelet GPVI expression and signaling in a patient with myelodysplastic syndrome (MDS) and a collagen-selective defect.
  • To investigate divergent pathways of ROS generation and Syk phosphorylation in human platelets.

Main Methods:

  • Quantification of GPVI surface expression and ligand-induced ROS generation using flow cytometry.
  • Analysis of GPVI shedding and Syk phosphorylation via Western blot.

Main Results:

  • Platelets exhibited normal GPVI surface expression but lacked aggregation response to collagen or GPVI-selective agonists.
  • Rapid GPVI-dependent, Syk-independent ROS generation and disulfide-dependent GPVI homodimerization were observed.
  • Ligand-induced platelet aggregation and GPVI ectodomain shedding were absent, while Syk phosphorylation occurred gradually.

Conclusions:

  • Platelet GPVI ligation induces ROS production independently of Syk activation.
  • Divergent pathways exist for ROS generation, platelet aggregation, and GPVI ectodomain shedding.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...